Asklepion Pharmaceuticals products
CHOLBAM (cholic acid, oral)
Indication: Treatment of bile acid synthesis disorders—due to single enzyme defects and as adjunctive therapy in peroxisomal disorders (e.g., Zellweger spectrum)
Status: FDA-approved as an oral therapy
Turnobi (intravenous L-citrulline)
Indications and Clinical Trials:
-
Prevention of acute lung injury in pediatric patients undergoing cardiopulmonary bypass for congenital heart defect surgery (Phase III clinical trial underway under FDA Special Protocol Assessment)
-
Treatment of vaso-occlusive crisis in pediatric and young adult patients with sickle cell disease (Phase I/II trial conducted)
No comments:
Post a Comment